Stock Events

Stock Events

Bicara Therapeutics (BCAX) Q4 2024 Earnings

12NovConfirmed

Q4 2024

-1.6

-1.2

-0.81

-0.41

Details

Expected EPS

-0.41

Actual EPS

-1.6

Surprise EPS

-1.19

Surprise Percent

+290.24%

Description

Bicara Therapeutics (BCAX) has reported earnings of -1.6 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.